MAAT INDEX

CLAIM #37137 · Eli Lilly and Company (LLY) · 2026Q1 earnings call · Apr 30, 2026 · due Dec 31, 2026

While we are currently having positive conversations and positive feedback from employers around this new platform that will most likely have a gradual impact in the back half of '26 and most likely incremental opt-ins for '27

Ilya Yuffa · President of Lilly USA

PENDING
graded after results covering Dec 31, 2026 are reported

How to check this claim

Look at: Impact/contribution from the new employer platform (e.g., incremental revenue, covered lives, or employer opt-ins), as disclosed by the company

It came true if: Company reports a gradual, positive impact from the platform beginning in H2 2026, with further incremental employer opt-ins disclosed for 2027

Where: Management commentary on quarterly earnings calls (Q3 2026 and Q4 2026 LLY earnings calls / investor materials)

Verify independently

SEC filings for LLY · Claim quote is verbatim from the 2026Q1 earnings call.